EFFICIENCY OF ENDOSCOPIC TREATMENT OF PRIMARY VESICOURETERAL REFLUX DEPENDING ON BULKING AGENT


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

From June 1991 to December 2011, endoscopic treatment of vesicoureteral reflux (VUR) was performed more than in 4,000 children aged 4 months to 17 years. As bulking agents, teflon paste, DAM +, urodex, and vantris were used. A comparative evaluation of the effectiveness of single endoplasty with various bulking agents in children with I-V degree primary VUR, who had no gross congenital abnormalities in ureterovesical anastomosis, such as paraureteral diverticula, complete duplicated ureter or extravesicalisation of ureter, and not suffered from chronic cystitis, was performed. It was found that the use of Teflon paste led to elimination of reflux in 102 (95.3%) of 107 patients, vantris - in 52 (92.9%) of 56 patients, DAM+ - in 145 (77.8%) of 186, urodex - in 47 (68.1%) of 69 patients. Among modern bulking agents meet all safety requirements, vantris is recommended for the optimal treatment of vesicoureteral reflux in children.

Full Text

Restricted Access

References

  1. Matouschek E. Treatment of vesicoureteral reflux by transurethral Teflon injection. Urologe Ausg. B. 1981; 20: 263-264.
  2. Puri P., Ninan G.K., Surana R. Subureteric Teflon injection (STING). Results of a European survey. Eur. Urol. 1995; 27 (1): 71-75.
  3. Dotat H., Takvorian P. Traitement endoscopique du reflux vesico-renal chez l'enfant. Le point sur trois annees d'experience et perspectives d'avenir. Ann. Chir. 1990; 44 (10): 824-829.
  4. Malizia A.A., Reiman H., Myers M. et al. Migration and granulomatous reaction after periurethral injection of Polytef (Teflon). JAMA 1984;251:3277-3281.
  5. Smith D.P., Kaplan W.E., Oyasu R. Does technique or material used affect bladder tissue reactions when injecting teflon or silicone paste? J. Urol. 1994; 152 (4): 1221-1224.
  6. Smith D.P., Beegle B.E., Noe H.N. et al. Does technique or material used affect bladder tissue reactions when injecting teflon or silicone paste? Urology. 1996; 48 (1): 119-123.
  7. Aubert D. Vesico-ureteric reflux treatment by implant of polydimethylsiloxane (Macroplastique): review of the literature. Prog. urol. 2010; 20(4): 251-259.
  8. Frey P., Curschellas E., Kaeslin M. Long-term histological results following glutaraldehyde cross-linked collagen injection into the suburothelial space of the mini-pig bladder. Pediatr. Surg. Int. 1991; 6: 252-260.
  9. Leonard M.P., Canning D.A., Peters C.A. Endoscopic injection of glutaraldehyde cross-linked bovine dermal collagen for correction of vesicoureteral reflux. J. Urol. 1991; 145 (1): 115-119.
  10. Haferkamp A., Mohring K., Staehler G. et al. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases. J. Urol. 2000;163(1):274-277.
  11. Atala A., Cima L. G., Kim W. et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J. Urol. 1993; 150(2):745-747.
  12. Atala A., Kim W., Paige K.T. et al. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J. Urol. 1994; 152 (2): 641-643.
  13. Chancellor M.B., Rivas D.A., Liberman S.N. et al. Cystoscopic autogenous fat injection treatment of vesicoureteral reflux in spinal cord injury. J. Am. Paraplegia Soc. 1994;17(2):50-54.
  14. Matthews R.D., Christensen J.P., Canning D.A. Persistence of autologous free fat transplant in bladder submucosa of rats. J. Urol. 1994;152(2):819—821.
  15. Palma P.C., Ferreira U., Ikari O. et al. Subureteric lipoinjection for vesicoureteral reflux in renal transplant candidates. Urology. 1994;43(2): 174-177.
  16. Казачков С.А., Бабанин И.Л., Староверов О.В. и др. Эндоскопическое лечение ПМР у детей компонентами крови. Всероссийский сьезд урологов, 9-й: Тезисы докладов. Курск, 1997. С. 146-147.
  17. Stenberg A., Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J. Urol. 1995;154(2 Pt 2):800-803.
  18. Chen H.C., Yeh C.M., Chou C.M. Endoscopic treatment of vesicoureteral reflux in children with dextranomer/hyaluronic acid -a single surgeon's 6-year experience. Diagn. Ther. Endosc. 2010; 2010. ріі: 278012.
  19. Osipov I., Lebedev D., Sosnin E. et al. Our experience in endoscopic treatment of vesico-ureteral reflux in children. Arch. Ital. Urol. Androl. 2005;77(3):146—148.
  20. Ormaechea M., Paladini M., Pisano R. et al. Vantris, a biocompatible, synthetic, non-biodegradable, easy-to-inject bulking substance. Evaluation of local tissular reaction, localized migration and longdistance migration. Arch. Esp. Urol. 2008;61(2):263-268.
  21. Ormaechea M., Ruiz E., Denes E. et al. New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children. Urol. 2010; 183 (2): 714-717.
  22. Chertin B., Arafeh W.A., Zeldin A. et al. Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris®): surgical outcome following single injection. J. Pediatr. Urol. 2011;7(6):654-657.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies